يعرض 1 - 10 نتائج من 78 نتيجة بحث عن '"Straume, O."', وقت الاستعلام: 1.48s تنقيح النتائج
  1. 1
    دورية أكاديمية
    BRAF and NRAS mutations are frequent in nodular melanoma but are not associated with tumor cell proliferation or patient survival

    المؤلفون: Akslen, LA, Angelini, S, Straume, O, Bachmann, IM, Molven, A, Hemminki, K, Kumar, R

    المصدر: The Journal of investigative dermatology. 125(2):312-317

    مصطلحات موضوعية: Medicin och hälsovetenskap

    الوصول الحر: http://kipublications.ki.se/Default.aspx?queryparsed=id:111283647Test

    View record in SwePub النص الكامل

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Significant impact of promoter hypermethylation and the 540 C>T polymorphism of CDKN2A in cutaneous melanoma of the vertical growth phase

    المؤلفون: Straume, O, Smeds, J, Kumar, R, Hemminki, K, Akslen, LA

    المصدر: The American journal of pathology. 161(1):229-237

    مصطلحات موضوعية: Medicin och hälsovetenskap

    الوصول الحر: http://kipublications.ki.se/Default.aspx?queryparsed=id:1947290Test

    View record in SwePub النص الكامل

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Health-related quality of life in patients with advanced melanoma treated with ipilimumab: prognostic implications and changes during treatment

    المؤلفون: Aamdal, E., Skovlund, E., Jacobsen, K.D., Straume, O., Kersten, C., Herlofsen, O., Karlsen, J., Hussain, I., Amundsen, A., Dalhaug, A., Nyakas, M., Hagene, K.T., Holmsen, K., Aamdal, S., Kaasa, S., Guren, T.K., Kyte, J.A.

    المصدر: ESMO Open ; volume 7, issue 5, page 100588 ; ISSN 2059-7029

    مصطلحات موضوعية: Cancer Research, Oncology

    الإتاحة: https://doi.org/10.1016/j.esmoop.2022.100588Test
    https://api.elsevier.com/content/article/PII:S2059702922002186?httpAccept=text/xmlTest
    https://api.elsevier.com/content/article/PII:S2059702922002186?httpAccept=text/plainTest

    View record in BASE

    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity : clinical outcomes in advanced melanoma

    المؤلفون: Jansen, Y. J. L., Rozeman, E. A., Mason, R., Goldinger, S. M., Foppen, M. H. Geukes, Hoejberg, L., Schmidt, H., van Thienen, J., Haanen, J. B. A. G., Tiainen, L., Svane, I. M., Mäkelä, S., Seremet, T., Arance, A., Dummer, R., Bastholt, L., Nyakas, M., Straume, O., Menzies, A. M., Long, G., Atkinson, Jeffrey, Blank, C. U., Neyns, B.

    المساهمون: HUS Comprehensive Cancer Center, Department of Oncology, University of Helsinki

    مصطلحات موضوعية: melanoma, anti-PD-1 therapy, duration of treatment, immunotherapy, COMBINED NIVOLUMAB, SURVIVAL, PEMBROLIZUMAB, IPILIMUMAB, MONOTHERAPY, PROFILE, SAFETY, 3122 Cancers

    وصف الملف: application/pdf

    العلاقة: Jansen , Y J L , Rozeman , E A , Mason , R , Goldinger , S M , Foppen , M H G , Hoejberg , L , Schmidt , H , van Thienen , J , Haanen , J B A G , Tiainen , L , Svane , I M , Mäkelä , S , Seremet , T , Arance , A , Dummer , R , Bastholt , L , Nyakas , M , Straume , O , Menzies , A M , Long , G , Atkinson , J , Blank , C U & Neyns , B 2019 , ' Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity : clinical outcomes in advanced melanoma ' , Annals of Oncology , vol. 30 , no. 7 , pp. 1154-1161 . https://doi.org/10.1093/annonc/mdz110Test; ea02842f-2f3b-4341-a3be-9d44ae4ffa41; http://hdl.handle.net/10138/310955Test; 000484369900022

    الإتاحة: http://hdl.handle.net/10138/310955Test

    View record in BASE

    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    AXL Is a Driver of Stemness in Normal Mammary Gland and Breast Cancer

    المؤلفون: Engelsen, A.S.T., Wnuk-Lipinska, K., Bougnaud, S., Pelissier Vatter, F.A., Tiron, C., Villadsen, R., Miyano, M., Lotsberg, M.L., Madeleine, N., Panahandeh, P., Dhakal, S., Tan, T.Z., Peters, S.D., Grøndal, S., Aziz, S.M., Nord, S., Herfindal, L., Stampfer, M.R., Sørlie, T., Brekken, R.A., Straume, O., Halberg, N., Gausdal, G., Thiery, J.P., Akslen, L.A., Petersen, O.W., LaBarge, M.A., Lorens, J.B.

    المساهمون: CANCER SCIENCE INSTITUTE OF SINGAPORE, DEPT OF BIOCHEMISTRY

    المصدر: Scopus OA2020

    مصطلحات موضوعية: Cancer, Cell Biology, Stem Cells Research

    العلاقة: Engelsen, A.S.T., Wnuk-Lipinska, K., Bougnaud, S., Pelissier Vatter, F.A., Tiron, C., Villadsen, R., Miyano, M., Lotsberg, M.L., Madeleine, N., Panahandeh, P., Dhakal, S., Tan, T.Z., Peters, S.D., Grøndal, S., Aziz, S.M., Nord, S., Herfindal, L., Stampfer, M.R., Sørlie, T., Brekken, R.A., Straume, O., Halberg, N., Gausdal, G., Thiery, J.P., Akslen, L.A., Petersen, O.W., LaBarge, M.A., Lorens, J.B. (2020). AXL Is a Driver of Stemness in Normal Mammary Gland and Breast Cancer. iScience 23 (11) : 101649. ScholarBank@NUS Repository. https://doi.org/10.1016/j.isci.2020.101649Test; https://scholarbank.nus.edu.sg/handle/10635/199374Test

    الإتاحة: https://doi.org/10.1016/j.isci.2020.101649Test
    https://scholarbank.nus.edu.sg/handle/10635/199374Test

    View record in BASE النص الكامل

    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    LBA52 A randomized phase Ib/II study of the selective small molecule AXL inhibitor bemcentinib in combination with either dabrafenib/trametinib or pembrolizumab in patients with metastatic melanoma

    المؤلفون: Straume, O., Schuster, C., Aziz, S., Davidsen, K., Karlsen, J., Rayford, A.J., Siraji, M.I., Løvendahl Svendsen, H., Reisæter, L., Gjertsen, B.T., Akslen, L., Lorens, J.

    المصدر: Annals of Oncology ; volume 34, page S1291 ; ISSN 0923-7534

    مصطلحات موضوعية: Oncology, Hematology

    الإتاحة: https://doi.org/10.1016/j.annonc.2023.10.046Test
    https://api.elsevier.com/content/article/PII:S092375342304190X?httpAccept=text/xmlTest
    https://api.elsevier.com/content/article/PII:S092375342304190X?httpAccept=text/plainTest

    View record in BASE

    أضف إلى المفضلة
  7. 7
    دورية أكاديمية
    Distant metastasis dynamics following subsequent surgeries after primary breast cancer removal

    المؤلفون: Demicheli R., Dillekas H., Straume O., Biganzoli E.

    المساهمون: R. Demicheli, H. Dilleka, O. Straume, E. Biganzoli

    مصطلحات موضوعية: Breast cancer, Metastasis development, Recurrence dynamic, Second surgery, Surgery-related metastasis acceleration, Tumour homeostasis, Settore MED/01 - Statistica Medica

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31046808; info:eu-repo/semantics/altIdentifier/wos/WOS:000467034400002; volume:21; issue:1; firstpage:1; lastpage:10; numberofpages:10; journal:BREAST CANCER RESEARCH; http://hdl.handle.net/2434/687943Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85065150054

    الإتاحة: https://doi.org/10.1186/s13058-019-1139-7Test
    http://hdl.handle.net/2434/687943Test

    View record in BASE

    أضف إلى المفضلة
  8. 8
    دورية أكاديمية
    Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity:clinical outcomes in advanced melanoma

    المؤلفون: Jansen, Y.J.L., Rozeman, E A, Mason, R, Goldinger, S M, Geukes Foppen, M H, Højberg, L., Schmidt, H., van Thienen, J V, Haanen, J B A G, Tiainen, L, Svane, I.M., Mäkelä, S, Seremet, T, Arance, A, Dummer, R, Bastholt, L, Nyakas, M, Straume, O, Menzies, A M, Long, G V, Atkinson, V, Blank, C U, Neyns, B

    المصدر: Jansen , Y J L , Rozeman , E A , Mason , R , Goldinger , S M , Geukes Foppen , M H , Højberg , L , Schmidt , H , van Thienen , J V , Haanen , J B A G , Tiainen , L , Svane , I M , Mäkelä , S , Seremet , T , Arance , A , Dummer , R , Bastholt , L , Nyakas , M , Straume , O , Menzies , A M , Long , G V , Atkinson , V , Blank ....

    وصف الملف: application/pdf

    الإتاحة: https://doi.org/10.1093/annonc/mdz110Test
    https://curis.ku.dk/portal/da/publications/discontinuation-of-antipd1-antibody-therapy-in-the-absence-of-disease-progression-or-treatment-limiting-toxicityTest(00dd1bed-a3b3-45b5-b8d4-f911468c6499).html
    https://curis.ku.dk/ws/files/237193570/1_s2.0_S092375341931227X_main.pdfTest

    View record in BASE

    أضف إلى المفضلة
  9. 9
    دورية أكاديمية
    A randomized phase Ib/II study of the selective small molecule Axl inhibitor bemcentinib (BGB324) in combination with either dabrafenib/trametinib (D/T) or pembrolizumab in patients with metastatic melanoma

    المؤلفون: Straume, O., Lorens, J.B., Gausdal, G., Gjertsen, B.T., Schuster, C.

    المصدر: Annals of Oncology ; volume 30, page v563 ; ISSN 0923-7534

    مصطلحات موضوعية: Oncology, Hematology

    الإتاحة: https://doi.org/10.1093/annonc/mdz255.025Test
    https://api.elsevier.com/content/article/PII:S0923753419595461?httpAccept=text/xmlTest
    https://api.elsevier.com/content/article/PII:S0923753419595461?httpAccept=text/plainTest
    http://academic.oup.com/annonc/article-pdf/30/Supplement_5/mdz255.025/30082968/mdz255.025.pdfTest

    View record in BASE

    أضف إلى المفضلة
  10. 10
    دورية أكاديمية
    Perioperative factors and complications after delayed reconstruction in breast cancer patients in relation to outcome

    المؤلفون: Dillekås, H.E., Kristoffersen, C.M., Jensen, S.A., Straume, O.

    المصدر: Annals of Oncology ; volume 30, page iii41 ; ISSN 0923-7534

    مصطلحات موضوعية: Oncology, Hematology

    الإتاحة: https://doi.org/10.1093/annonc/mdz098.006Test
    https://api.elsevier.com/content/article/PII:S0923753419303977?httpAccept=text/xmlTest
    https://api.elsevier.com/content/article/PII:S0923753419303977?httpAccept=text/plainTest
    http://academic.oup.com/annonc/article-pdf/30/Supplement_3/mdz098.006/28601112/mdz098.006.pdfTest

    View record in BASE

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث